Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine versus dexamethasone for prevention of cisplatin-induced nausea and vomiting
ChiCTR2000029615Phase 4Not yet recruiting
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of olanzapine, dexamethasone and aprepitant in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Complete response rate. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
olanzapinedexamethasoneaprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on ChiCTR2000029615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029615.